Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
International Journal of Clinical and Experimental Medicine
|
November 25, 2014
A retrospective study of the clinical differences of Uygur breast cancer patients compared to Han breast cancer patients in the Xinjiang region of China
Meihui Shan, Xiaoli Wang, Gang Sun, et al.
BMC Women'S Health
|
August 13, 2024
Correction: Use of ultrasound imaging Omics in predicting molecular typing and assessing the risk of postoperative recurrence in breast cancer
Xinyu Song, Haoyi Xu, Xiaoli Wang, et al.
Photodiagnosis and Photodynamic Therapy
|
September 12, 2022
Serum Raman spectroscopy combined with multiple classification models for rapid diagnosis of breast cancer
Hongtao Li, Shanshan Wang, Qinggang Zeng, et al.
Scientific Reports
|
November 24, 2024
Multimodal separation and cross fusion network based on Raman spectroscopy and FTIR spectroscopy for diagnosis of thyroid malignant tumor metastasis
Haitao Song, Xuguang Zhou, Cheng Chen, et al.
Frontiers in Oncology
|
May 8, 2026
Deciphering the potential of the C-reactive protein-albumin-lymphocyte index as a prognostic biomarker in malignancy: a systematic review and meta-analysis
Ziqian Zhao, Hongyi Yuan, Haoyi Xu, et al.
Cancer Medicine
|
October 17, 2020
Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China
Hongtao Li, Linghui Zhou, Jing Ma, et al.
Breast Cancer (Tokyo, Japan)
|
March 3, 2025
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a
Chao Dong, Yonghong Sun, Xiaoli Xu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 16, 2024
Tailoring Escalation Adjuvant Therapy for Early-Stage Triple-Negative Breast Cancer in the CBCSG010 Clinical Trial Biomarker Analysis
Wenya Wu, Yunsong Yang, Wentao Yang, et al.
Plos One
|
April 1, 2016
Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study
Ke Wang, Yu Ren, Hongyuan Li, et al.
BMJ Open
|
December 18, 2019
Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol
Lun Li, Benlong Yang, Hongyuan Li, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
International Journal of Clinical and Experimental Medicine
|
November 25, 2014
A retrospective study of the clinical differences of Uygur breast cancer patients compared to Han breast cancer patients in the Xinjiang region of China
Meihui Shan, Xiaoli Wang, Gang Sun, et al.
BMC Women'S Health
|
August 13, 2024
Correction: Use of ultrasound imaging Omics in predicting molecular typing and assessing the risk of postoperative recurrence in breast cancer
Xinyu Song, Haoyi Xu, Xiaoli Wang, et al.
Photodiagnosis and Photodynamic Therapy
|
September 12, 2022
Serum Raman spectroscopy combined with multiple classification models for rapid diagnosis of breast cancer
Hongtao Li, Shanshan Wang, Qinggang Zeng, et al.
Scientific Reports
|
November 24, 2024
Multimodal separation and cross fusion network based on Raman spectroscopy and FTIR spectroscopy for diagnosis of thyroid malignant tumor metastasis
Haitao Song, Xuguang Zhou, Cheng Chen, et al.
Frontiers in Oncology
|
May 8, 2026
Deciphering the potential of the C-reactive protein-albumin-lymphocyte index as a prognostic biomarker in malignancy: a systematic review and meta-analysis
Ziqian Zhao, Hongyi Yuan, Haoyi Xu, et al.
Cancer Medicine
|
October 17, 2020
Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China
Hongtao Li, Linghui Zhou, Jing Ma, et al.
Breast Cancer (Tokyo, Japan)
|
March 3, 2025
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a
Chao Dong, Yonghong Sun, Xiaoli Xu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 16, 2024
Tailoring Escalation Adjuvant Therapy for Early-Stage Triple-Negative Breast Cancer in the CBCSG010 Clinical Trial Biomarker Analysis
Wenya Wu, Yunsong Yang, Wentao Yang, et al.
Plos One
|
April 1, 2016
Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study
Ke Wang, Yu Ren, Hongyuan Li, et al.
BMJ Open
|
December 18, 2019
Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol
Lun Li, Benlong Yang, Hongyuan Li, et al.
Page
of 6